APN-1701

N/A

Report date: 2025/11/25 15:56:53
NME

Base Information

Drug NameAPN-1701
Drug Alias Nametau PET imaging tracerPBB3 tau PET tracer[18F]AM-PBB318F-AM-PBB3APN-1701
ClassificationSmall moleculesRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Fluorine > 18F +[5] 
Mechanisms of ActionMicrotubule-associated protein tau inhibitors
TargetsMicrotubule-associated protein tau
Therapy Area/IndicationsNerve DegenerationAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesNational Institute Of Radiological SciencesAprinoia Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNational Institute Of Radiological SciencesAprinoia Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsNerve DegenerationAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A